A behavioural Bayes approach for sample size determination in cluster randomized clinical trials

Journal of the Royal Statistical Society. Series C: Applied Statistics

Volumn 59, Issue 5, 2010, Pages 875-888

  Kikuchi, Takashi ^a   Gittins, John ^a  

^a UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

Behavioural Bayes approach; Cluster randomized clinical trials; Cost benefit; Sample size

Indexed keywords

EID: 77958582435     PISSN: 00359254     EISSN: 14679876     Source Type: Journal    
DOI: 10.1111/j.1467-9876.2010.00732.x     Document Type: Article

References (31)

1. Bernardo, J. and Smith, A. (1994) Bayesian Theory. Chichester: Wiley.
2. Christian, P., West, K. P., Khatry, S. K., LeClerq, S. C., Pradhan, E. K., Katz, J., Shrestha, S. R. and Sommer, A. (2003) Effects of maternal micronutrient supplementation on fetal loss and infant mortality: a cluster-randomized trial in Nepal. Am. Soc. Clin. Nutrn, 78, 1194-1202.
3. Connelly, L. (2003) Balancing the number and size of sites: an economic approach to the optimal design of cluster samples. Contr. Clin. Trials, 24, 544-559.
4. Donner, A. (1992) Sample size requirements for stratified cluster randomization designs. Statist. Med., 11, 743-750.
5. Donner, A., Brikett, N. and Buck, C. (1981) Randomization by cluster: sample size requirements and analysis. Am. J. Epidem., 114, 906-914.
6. Ebrahim, S., Lampe, F., Wannamthee, G. and Smith, G. (1998) Cholesterol and coronary heart disease: screening and treatment. Effectv. Hlth Care, 4, 1-16.
7. Gail, M., Byar, D., Pechacek, T. and Corle, D. (1992) Aspects of statistical design for the Community Intervention Trial for Smoking Cessation. Contr. Clin. Trials, 13, 6-21.
8. Gittins, J. and Pezeshk, H. (2000a) A behavioral Bayes method for determining the size of a clinical trial. Drug Inform. J., 34, 355-363.
9. Gittins, J. and Pezeshk, H. (2000b) How large should a clinical trial be? Statistician, 49, 177-187.
10. Gittins, J. and Pezeshk, H. (2002a) A decision theoretic approach to sample size determination in clinical trials. J. Biopharm. Statist., 12, 535-551.
11. Gittins, J. and Pezeshk, H. (2002b) A fully Bayesian approach to calculating sample sizes for clinical trials with binary responses. Drug Inform. J., 36, 143-150.
12. Hayes, R. and Bennett, S. (1999) Simple sample size calculation for cluster-randomized trials. Int. J. Epidem., 28, 319-326.
13. Kikuchi, T. and Gittins, J. (2009) A behavioral Bayes method to determine the sample size of a clinical trial considering efficacy and safety. Statist. Med., 28, 2293-2306.
14. Kikuchi, T. and Gittins, J. (2010a) A Bayesian adaptive design for the evaluation of a new drug in a bridging study. To be published.
15. Kikuchi, T. and Gittins, J. (2010b) A behavioral Bayes approach to the determination of sample size for clinical trials considering efficacy and safety: imbalanced sample size in treatment groups. Statist. Meth. Med. Res., to be published.
16. Kikuchi, T., Pezeshk, H. and Gittins, J. (2008) A Bayesian cost-benefit approach to the determination of sample size in clinical trials. Statist. Med., 27, 68-82.
17. Kocpsell, T., Martin, D. and Dichr, P. (1991) Data analysis and sample size issues in evaluations of community-based health promotion and disease prevention programs: a mixed-model analysis of variance approach. J. Clin. Epidem., 44, 701-713.
18. Petersen, S., Peto, V. and Rayner, M. (2004) Coronary Heart Disease Statistics 2004. London: British Heart Foundation.
19. Pickin, D., McCabe, C., Ramsay, L., Payne, N., Haq, I., Yeo, W. and Jackson, P. (1999) Cost effectiveness of HMG-CoA reductase inhibitor (statin) treatment related to the risk of coronary heart disease and cost of drug treatment. Heart, 82, 325-332.
20. Shaper, A., Pocock, S., Walker, M., Choen, N., Wale, C. and Thompson, A. (1981) British regional heart study: cardiovascular risk factors in middle-aged men in 24 towns. Br. Med. J., 283, 179-186.
21. Shipley, M., Smith, P. and Dramix, M. (1989) Calculation of power for matched pair studies when randomization is by group. Int. J. Epidem., 18, 457-461.
22. Shoukri, M. and Martin, S. (1992) Estimating the number of clusters for the analysis of correlated binary response variables from unbalanced data. Statist. Med., 11, 751-760.
23. Smith, P. and Morrow, R. (1996) Field Trials of Health Interventions in Developing Countries: a Toolbox. London: Macmillan.
24. Spiegelhalter, D. (2001) Bayesian methods of analysis for cluster randomized trials with continuous responses. Statist. Med., 20, 453-462.
25. Thompson, S., Pyke, S. D. and Hardy, R. J. (1997) The design and analysis of paired cluster randomized trials: an application of meta-analysis techniques. Statist. Med., 16, 2063-2079.
26. Thompson, S., Warn, D. and Turner, R. (2004) Bayesian methods of analysis for binary outcome data in cluster randomized trials on the absolute risk scale. Statist. Med., 23, 389-410.
27. Tunstall-Pedoe, H. (1991) The Dundee coronary risk disk for management of change in risk factors. Br. Med. J., 303, 744-747.
28. Turner, R., Omar, R. and Thompson, S. (2001) Bayesian methods of analysis for cluster randomized trials with binary outcome data. Statist. Med., 20, 453-472.
29. Wonderling, D., McDermott, C., Buxton, M., Kinmonth, A., Pyke, S., Thompson, S. and Wood, D. (1996) Costs and cost effectiveness of cardiovascular screening and intervention: the British family heart study. Br. Med. J., 312, 1269-1273.
30. Wood, D., Kinmonth, A., Davies, G., Yarwood, J., Thompson, S., Pyke, S., Kok, Y., Cramb, R., Guen, C., Marteau, T. and Durrington, P. (1994a) British family heart study: its design and method and prevalence of cardiovascular risk factors. Br. J. Gen. Pract., 44, 62-67.
31. Wood, D., Kinmonth, A., Davies, G., Yarwood, J., Thompson, S., Pyke, S., Kok, Y., Cramb, R., Guen, C., Marteau, T. and Durrington, P. (1994b) Randomised controlled trial evaluating cardiovascular screening and intervention in general practice: principal results of British family heart study. Br. Med. J., 308, 313-320.